NAMESON Holdings (01982) has been granted a three-year loan financing with a maximum total amount of up to 200 million Hong Kong dollars.
South China Holdings (01982) announces that on March 20, 2026, the Company (as the borrower) has entered into a financing letter with a bank (as the lender) for a three-year term loan financing with a maximum total amount of HK$200 million.
NAMESON HLDGS (01982) announced that on March 20, 2026, the company (as the borrower) entered into a financing letter with a bank (as the lender) for a three-year term loan financing of up to HK$200 million.
Related Articles
HENLIUS (02696) announced its annual performance, with revenue of 6.67 billion RMB, representing a year-on-year growth of 16.46%.
Shengtak New Materials (300881.SZ) has received approval from the Shenzhen Stock Exchange for the issuance of convertible bonds.
HENLIUS (02696)Naluriyou monoclonal anti-drug similar to drug HLX18 (recombinant humanized monoclonal antibody injection) for the treatment of various solid tumors has received approval from the National Medical Products Administration for phase 1 clinical trial application.
HENLIUS (02696) announced its annual performance, with revenue of 6.67 billion RMB, representing a year-on-year growth of 16.46%.
Shengtak New Materials (300881.SZ) has received approval from the Shenzhen Stock Exchange for the issuance of convertible bonds.
HENLIUS (02696)Naluriyou monoclonal anti-drug similar to drug HLX18 (recombinant humanized monoclonal antibody injection) for the treatment of various solid tumors has received approval from the National Medical Products Administration for phase 1 clinical trial application.
RECOMMEND
State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026
Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026
Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026
